Effects of Articaine Computer-controlled and Conventional Delivery for Anterior and Middle Superior Alveolar Nerve Block for Tooth Extraction
NCT ID: NCT03225326
Last Updated: 2018-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
INTERVENTIONAL
2016-12-31
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of 4% Articaine Terminal Anesthesia in the Lateral Jaw Region in Children
NCT05423392
Articaine and Bupivacaine in Impacted Tooth Surgery
NCT04645888
Comparing Articaine and Mepivacaine Without Palatal Injection in Pain Assessment During Maxillary Teeth Extraction
NCT03470532
Efficacy and Safety of Administration of Different Doses of 4% Articaine.
NCT06644950
Comparison of the Effectiveness of Articaine Local Infusion and Lidocaine Nerve Block in Lower Posterior Tooth Extraction.
NCT07048834
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Computer controlled 4% articaine delivery by Anaeject
Computer controlled 4% articaine delivery by Anaeject
Single dose of 0.6ml 4% articaine with epinephrine (1:100.000) delivered by computer controlled local anesthetic delivery system (Anaeject)
Conventional 4% articaine delivery by carpule syringe
Conventional 4% articaine delivery by carpule syringe
Single dose of 0.6ml 4% articaine with epinephrine (1:100.000) delivered by conventional syringe (carpule syringe).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Computer controlled 4% articaine delivery by Anaeject
Single dose of 0.6ml 4% articaine with epinephrine (1:100.000) delivered by computer controlled local anesthetic delivery system (Anaeject)
Conventional 4% articaine delivery by carpule syringe
Single dose of 0.6ml 4% articaine with epinephrine (1:100.000) delivered by conventional syringe (carpule syringe).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* maxillary incisors canines or premolars indicated for extraction due to periapical pathology, root fracture or orthodontic treatment
Exclusion Criteria
* alcohol and drugs abuse
* heavy tobacco smoking
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Belgrade
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bozidar Brkovic, DDS, MSc, PhD, Professor
DDS PhD Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marija Milić, Research Associate
Role: PRINCIPAL_INVESTIGATOR
School of Dental Medicine, University of Belgrade
Vladimir Biočanin, Assistant Professor
Role: PRINCIPAL_INVESTIGATOR
Faculty of Pharmacy and Health, University of Travnik, Bosnia and Herzegovina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Dental Medicine, University of Belgrade
Belgrade, , Serbia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UBelgrade 784/2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.